FDA OKs Sub-Q Vedolizumab for Crohn’s Maintenance Therapy FDA OKs Sub-Q Vedolizumab for Crohn’s Maintenance Therapy

Subcutaneous administration of vedolizumab is now approved for maintenance therapy in adults with moderate to severe active Crohn’s disease after induction therapy with intravenous vedolizumab.Medscape Medical News (Source: Medscape Today Headlines)